Ulrich Kruse
Investment Manager @ TRUMPF Venture
Ditzingen, Germany
Ulrich Kruse is a Series A investor at TRUMPF Venture in Ditzingen focused on Software and Medical. Ulrich Kruse is the Investment Manager at TRUMPF Venture. Attended IESE Business School.
- Total investments:
- 5
- Last investment:
- Lead investor:
- 100%
Last updated:
For AI agents: llms.txt
Industries Ulrich Kruse invests in
Stages Ulrich Kruse invests in
Countries Ulrich Kruse invests in
Investment Focus
Industry
- Software 2 (40%)
- Medical 1 (20%)
- Security 1 (20%)
- Health Care 1 (20%)
- Biotechnology 1 (20%)
Stage
- Series A 1 (20%)
- Series D 1 (20%)
- Funding Round 1 (20%)
- Venture - Series Unknown 1 (20%)
Country
- Germany 2 (40%)
- Spain 1 (20%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
Quside
|
Quside is a Barcelona-based startup that designs and manufactures innovative quantum components for any connected device. Using their proprietary quantum random number generation technology, they are enabling the next generation of encryption solutions. | $11M / Series A / Jul 04, 2023 | |
nyris
|
Text-based search is a source of costly friction—especially for companies that manage products, component parts or other items that are essential to customer, supplier or employee. nyris is a visual search platform that gives people a more natural way to find what they are looking for. With nyris, companies of all industries realize financial valuewhile improving how people find, discover and get things done. Up and running in minutes, only nyris’ technology is designed and engineered to handle any search challenge. Based in Berlin and Dusseldorf, nyris serves leading companies across Retail & E-Commerce; Industrial & Manufacturing; Media & Entertainment; and Financial Services. nyris serves customers in more than 50 countries and representing every continent. Led by respected technology industry veterans, nyris investors include eCapital, IKEA and Axel Springer. | $10.9M / Venture - Series Unknown / Mar 30, 2023 | |
iThera Medical
|
iThera Medical offers access to innovative technology and know-how in photonic molecular imaging. The company was founded in 2010, as a spin-off from the Helmholtz Zentrum Muenchen, the German Research Center for Environmental Health (HMGU). Together, they pursue the further development of proprietary MSOT technology for use in preclinical andclinical applications. | $14.3M / Dec 21, 2022 | |
|
iThera Medical
|
iThera Medical offers access to innovative technology and know-how in photonic molecular imaging. The company was founded in 2010, as a spin-off from the Helmholtz Zentrum Muenchen, the German Research Center for Environmental Health (HMGU). Together, they pursue the further development of proprietary MSOT technology for use in preclinical andclinical applications. | $13.8M / Series D / Dec 21, 2022 | |
|
Quside
|
Quside is a Barcelona-based startup that designs and manufactures innovative quantum components for any connected device. Using their proprietary quantum random number generation technology, they are enabling the next generation of encryption solutions. | Series A / Nov 30, 2022 |
Co-Investors
About TRUMPF Venture
The corporate venture capital arm TRUMPF Venture extends TRUMPF’s comprehensive activities to promote innovation and to detect disruptive technologies and business models early on. TRUMPF is the world technological and market leader for machine tools used in flexible sheet metal processing as well as industrial lasers. TRUMPF Venture investsglobally in early-stage start-ups active in areas complementary or adjacent to the TRUMPF core, such as Advances Photonics and Smart Factory. Funded start-ups benefit from an extensive network, deep domain knowhow, proven skills in scalability as well as support to access the TRUMPF group and its ecosystem. The requirements for a potential investment are a strategic fit, a high innovation leverage and differentiation in business model or technology, an experienced management team and risk adequate financial returns.
TRUMPF Venture Contacts
| Name | Phone | Socials | |
|---|---|---|---|
|
Ulrich Kruse
Investment Manager
|
|||
Dieter Kraft
Managing Director
|
|||
Jens Ortgiese
Principal
|
|||
2 more contacts available
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar stage
Recommended lists
FAQ
What does Ulrich Kruse invest in?
Ulrich Kruse invests primarily in Software, Medical and Security startups, most often at Series A and Series D stage. Most of the 5 investments tracked by Shizune back companies in Germany. The Investment Focus section breaks down every industry, stage and country in the portfolio.
When did Ulrich Kruse last invest?
The most recent investment recorded for Ulrich Kruse closed in Jul 2023. Shizune tracks 5 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
